Noting the relevant three-year limitations provision was “quite unusal”, the judge overseeing a consumer class action against horse vaccine manufacturer Zoetis has given the class a chance to add a second applicant to the case, after it was revealed that part of the lead applicant’s claim was out of time.
Monsanto faces first Australian lawsuit over RoundUp weedkiller
Treasury Wine wins costs from solicitor’s company over stayed class action
NSW Ports hit with second competition lawsuit over ports agreement
Suncorp faces class action over superannuation fees
Bayer faces appeals of IP Australia rulings on antiseptic patent
Ex-CFO of Octaviar unit charged with $4.6M fraud
Botox alternatives likened to ‘iPhone accessories’ as trade mark trial kicks off
In its opening submissions in a trade mark case brought by Botox maker Allergan, Australian cosmetics brand Self Care compared its used of the word Botox to describe its alternative cosmetic products to the iPhone secondary accessories market, saying its use did not imply an affiliation with the injectable wrinkle treatment’s maker.